Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder

NCT00277654 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder
Anxiety Disorder

Interventions

DRUG: Risperidone

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]